Market News

DRIVEN BY STRONG DEMAND, IMMUNITYBIO REPORTS 467% YEAR-TO-DATE UNIT GROWTH AND $75 MILLION IN SALES YEAR-TO-DATE, UP 434% FROM Q3 2024

CULVER CITY, CALIF.--(BUSINESS WIRE)--IMMUNITYBIO, INC. (NASDAQ: IBRX), A LEADING IMMUNOTHERAPY COMPANY, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE FISCAL QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2025. IN THE THIRD QUARTER OF 2025, IMMUNITYBIO REPORTED $31.8 MILLION OF PRODUCT REVENUE, REPRESENTING A 434% INCREASE FROM $6.0 MILLION IN THE THIRD QUARTER OF 2024. THIS GROWTH REFLECTS CONTINUED COMMERCIAL TRACTION OF ANKTIVA IN COMBINATION WITH BCG IN BCG-UNRESPONSIVE NMIBC WITH CIS WITH OR.

IBRX • Nov. 4, 2025

EPWK HOLDINGS LTD. ANNOUNCES RECEIPT OF NASDAQ DELISTING NOTIFICATION LETTER

XIAMEN, CHINA , NOV. 4, 2025 /PRNEWSWIRE/ -- EPWK HOLDINGS LTD. (NASDAQ: EPWK) (THE "COMPANY"), A COMPANY THAT CONNECTS BUSINESSES WITH GREAT TALENTS THROUGH INNOVATIVE AND EFFICIENT CLOUD-SOURCING PLATFORMS, TODAY ANNOUNCED THAT THE COMPANY RECEIVED A LETTER (THE "NOTIFICATION LETTER") FROM THE LISTING QUALIFICATIONS STAFF (THE "STAFF") OF THE NASDAQ STOCK MARKET, LLC ("NASDAQ"), NOTIFYING THE COMPANY THAT, AS OF OCTOBER 23, 2025, THE COMPANY'S CLASS A ORDINARY SHARES HAD A CLOSING BID PRICE OF $0.10 OR LESS FOR TEN CONSECUTIVE TRADING DAYS, AND ACCORDINGLY, THE COMPANY IS SUBJECT TO THE PROVISIONS CONTEMPLATED UNDER LISTING RULE 5810(C)(3)(A)(III).

EPWK • Nov. 4, 2025

ATYR INVESTORS HAVE OPPORTUNITY TO LEAD ATYR PHARMA, INC. SECURITIES FRAUD LAWSUIT

NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF ATYR PHARMA, INC. (NASDAQ: ATYR) BETWEEN JANUARY 16, 2025 AND SEPTEMBER 12, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 8, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED ATYR PHARMA COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.

ATYR • Nov. 4, 2025

BAX INVESTORS HAVE OPPORTUNITY TO LEAD BAXTER INTERNATIONAL INC. SECURITIES FRAUD LAWSUIT

NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF BAXTER INTERNATIONAL INC. (NYSE: BAX) BETWEEN FEBRUARY 23, 2022 AND JULY 30, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 15, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED BAXTER COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.

BAX • Nov. 4, 2025

CYTK INVESTORS HAVE OPPORTUNITY TO LEAD CYTOKINETICS, INC. SECURITIES FRAUD LAWSUIT

NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF CYTOKINETICS, INC. (NASDAQ: CYTK) BETWEEN DECEMBER 27, 2023 AND MAY 6, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 17, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED CYTOKINETICS COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.

CYTK • Nov. 4, 2025

DAT ALERT: ALPHATON CAPITAL ACQUIRES 300,000 ADDITIONAL TON

LONDON, UK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- ALPHATON CAPITAL CORP ("ALPHATON CAPITAL" OR THE "COMPANY") ( NASDAQ: ATON) - ALPHATON CAPITAL, A LEADING INVESTMENT FIRM FOCUSED ON DISRUPTIVE TECHNOLOGIES, TODAY ANNOUNCED IT HAS ACQUIRED AN ADDITIONAL 300,000 TON COIN TO ADD TO ITS TON DIGITAL ASSET TREASURY.

ATON • Nov. 4, 2025

COREBRIDGE FINANCIAL ANNOUNCES PRICING OF SECONDARY OFFERING OF COMMON STOCK BY AIG

HOUSTON--(BUSINESS WIRE)--COREBRIDGE FINANCIAL, INC. (NYSE: CRBG) TODAY ANNOUNCED THAT THE PREVIOUSLY ANNOUNCED SECONDARY OFFERING BY AMERICAN INTERNATIONAL GROUP, INC. (NYSE: AIG) OF COMMON STOCK OF COREBRIDGE FINANCIAL HAS PRICED AT $31.10 PER SHARE. THE OFFERING IS EXPECTED TO CLOSE ON NOVEMBER 6, 2025, SUBJECT TO CUSTOMARY CLOSING CONDITIONS. AIG, AS THE SELLING STOCKHOLDER, HAS OFFERED 32.6 MILLION EXISTING SHARES OF COMMON STOCK (OUT OF APPROXIMATELY 520 MILLION TOTAL SHARES OF COMMON STO.

CRBG • Nov. 4, 2025

THE ESTÉE LAUDER COMPANIES ANNOUNCES PRICING OF SECONDARY OFFERING OF CLASS A COMMON STOCK BY SELLING STOCKHOLDERS

NEW YORK--(BUSINESS WIRE)--THE ESTÉE LAUDER COMPANIES INC. (NYSE: EL) TODAY ANNOUNCES THE PRICING OF THE PREVIOUSLY ANNOUNCED REGISTERED PUBLIC OFFERING (THE “OFFERING”) OF THE COMPANY'S CLASS A COMMON STOCK, PAR VALUE $.01 PER SHARE, BY TRUSTS AFFILIATED WITH DESCENDANTS OF LEONARD A. LAUDER (THE “SELLING STOCKHOLDERS”) AT A PRICE TO THE PUBLIC OF $90 PER SHARE. THE SELLING STOCKHOLDERS WILL RECEIVE ALL OF THE PROCEEDS FROM THE OFFERING. THE COMPANY IS NOT SELLING ANY SHARES OF CLASS A COMMON.

EL • Nov. 4, 2025

FDA ISSUES COMPLETE RESPONSE LETTER FOR BIOHAVEN'S VYGLXIA (TRORILUZOLE) NEW DRUG APPLICATION FOR SPINOCEREBELLAR ATAXIA

THE TRORILUZOLE CLINICAL DEVELOPMENT PROGRAM ENCOMPASSED THE FIRST INDUSTRY CLINICAL TRIALS TO GENERATE DATA SHOWING THERAPEUTIC POTENTIAL IN PATIENTS WITH SPINOCEREBELLAR ATAXIA (SCA), A RARE GENETIC, INHERITED, LIFE-THREATENING NEURODEGENERATIVE DISEASE WITH NO TREATMENT OPTIONS. COMPELLING DATA FROM TRORILUZOLE'S NEW DRUG APPLICATION (NDA) INCLUDED: A 3-YEAR REAL-WORLD EVIDENCE STUDY (STUDY 206-RWE) SHOWING SLOWING OF SCA DISEASE PROGRESSION BY 50-70% IN TRORILUZOLE-TREATED PATIENTS COMPARED TO MATCHED UNTREATED EXTERNAL CONTROLS; > 50% RISK REDUCTION IN AES OF FALLS IN TRORILUZOLE-TREATED SUBJECTS COMPARED TO PLACEBO FROM THE SAFETY ANALYSIS OF THE 1-YEAR, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY -206; AND MULTIPLE SUPPORTIVE ANALYSES SHOWING A DELAY IN BECOMING WHEELCHAIR BOUND OR LOSING THE ABILITY TO WALK, DECREASED GAIT IMPAIRMENT AS MEASURED BY F-SARA AND OBJECTIVE VIDEO-BASED KINEMATIC ANALYSIS, AND IMPROVEMENT IN OVERALL FUNCTIONING AS ASSESSED BY THE CLINICIAN GLOBAL IMPRESSION (CGI) SCALE.

BHVN • Nov. 4, 2025

BLUE STAR GOLD ANNOUNCES CLOSING OF FIRST TRANCHE OF NON-BROKERED PRIVATE PLACEMENT

VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - NOVEMBER 4, 2025) - BLUE STAR GOLD CORP. (TSXV: BAU) (OTCQB: BAUFF) (FSE: 5WP0) ("BLUE STAR" OR THE "COMPANY") ANNOUNCES THAT, FURTHER TO ITS NEWS RELEASE OF OCTOBER 30, 2025, IT HAS CLOSED THE FIRST TRANCHE OF ITS NON-BROKERED PRIVATE PLACEMENT RAISING PROCEEDS OF $1,250,000 THROUGH THE ISSUANCE OF 5,000,000 FLOW-THROUGH COMMON SHARES (EACH, A "FT SHARE") AT $0.25 PER FT SHARE (THE "PRIVATE PLACEMENT"). THE FT SHARES WILL QUALIFY AS FLOW-THROUGH SHARES FOR PURPOSES OF THE INCOME TAX ACT (CANADA).

BAUFF • Nov. 4, 2025

LAW OFFICES OF HOWARD G. SMITH ENCOURAGES CARMAX, INC. (KMX) SHAREHOLDERS TO INQUIRE ABOUT SECURITIES FRAUD CLASS ACTION

BENSALEM, PA.--(BUSINESS WIRE)--LAW OFFICES OF HOWARD G. SMITH ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF INVESTORS WHO PURCHASED CARMAX, INC. (“CARMAX” OR THE “COMPANY”) (NYSE: KMX) SECURITIES BETWEEN JUNE 20, 2025 AND SEPTEMBER 24, 2025, INCLUSIVE (THE “CLASS PERIOD”). CARMAX INVESTORS HAVE UNTIL JANUARY 2, 2026 TO FILE A LEAD PLAINTIFF MOTION. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CARMAX, INC. (KMX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN.

KMX • Nov. 4, 2025

ASCLETIS PRESENTS FULL ANALYSIS OF PHASE IB STUDY OF ASC30 ORAL TABLET, PHASE IB STUDY OF ASC30 INJECTION, AND PRECLINICAL STUDY OF COMBINATION OF ASC31 AND ASC47 AT OBESITYWEEK® 2025

-POSITIVE DATA FROM PHASE IB STUDY OF ASC30 ORAL TABLET DEMONSTRATED UP TO 6.5% PLACEBO-ADJUSTED MEAN BODY WEIGHT REDUCTION; SAFE AND WELL TOLERATED WITH ONLY MILD-TO-MODERATE GASTROINTESTINAL (GI) ADVERSE EVENTS (AES) ACROSS ALL MULTIPLE ASCENDING DOSE (MAD) COHORTS. -PHASE IB STUDY DATA OF ASC30 SUBCUTANEOUS (SQ) INJECTION SHOWED THAT OBSERVED HALF-LIFE REACHED 46 DAYS FOR THE TREATMENT FORMULATION (INJECTION A) AND 75 DAYS FOR THE MAINTENANCE FORMULATION (INJECTION B).

ASCLF • Nov. 4, 2025

OMDIA: DISPLAY GLASS REVENUE REACHED A RECORD HIGH OF JPY 270 BILLION IN 3Q 2025

LONDON--(BUSINESS WIRE)-- #DISPLAY--DISPLAY GLASS REVENUE REACHED A RECORD HIGH OF JPY 270 BILLION IN THE THIRD QUARTER OF 2025, DRIVEN BY INCREASES IN BOTH PRICE AND DEMAND, ACCORDING TO NEW RESEARCH FROM OMDIA. THIS REVENUE REPRESENTS A 5% QUARTER-OVER-QUARTER (QOQ) INCREASE AND 14% YEAR-OVER-YEAR (YOY) INCREASE. DISPLAY GLASS IS STILL TRADED IN JAPANESE YEN. STRONG REVENUE PERFORMANCE IN 3Q25 REFLECTS A SIGNIFICANT STRATEGIC SHIFT IN THE INDUSTRY. AFTER A SEVERE RECESSION IN 2011, GLASS MAKERS ENDURED.

TTGT • Nov. 4, 2025

MULTIPLE RESEARCH RESULTS FROM INNOVENT'S GENERAL BIOMEDICINE PIPELINE SHOWCASED AT 2025 ACR ANNUAL MEETING

SAN FRANCISCO AND SUZHOU, CHINA , NOV. 4, 2025 /PRNEWSWIRE/ -- INNOVENT BIOLOGICS, INC. ("INNOVENT") (HKEX: 01801), A WORLD-CLASS BIOPHARMACEUTICAL COMPANY THAT DEVELOPS, MANUFACTURES, AND COMMERCIALIZES HIGH-QUALITY MEDICINES FOR THE TREATMENT OF ONCOLOGY, AUTOIMMUNE, CARDIOVASCULAR AND METABOLIC, OPHTHALMOLOGY AND OTHER MAJOR DISEASE AREAS, ANNOUNCED THAT PRE-CLINICAL STUDY RESULTS OF IBI3011 (IL-1RAP MONOCLONAL ANTIBODY) AND IBI3034 (TACI/BCMA CHIMERIC FUSION PROTEIN) WERE SHOWCASED AT AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) ANNUAL MEETING 2025. DETAILS ARE LISTED BELOW: TITLE: IBI3011, A HUMANIZED ANTI-IL1RAP MONOCLONAL ANTIBODY, INHIBITS IL1, IL33, IL36-DRIVEN INFLAMMATION PATHWAY, AND ATTENUATES INFLAMMATION IN PRECLINICAL INFLAMMATORY DISEASE MODEL (IBI3011) ABSTRACT NUMBER : 0082 PRESENTATION FORM: POSTER TIME: OCTOBER 26, 2025 10:30 AM – 12:30 PM (CT) PRESENTER: DR. HONGLING TIAN IBI3011 IS AN INNOVATIVE HUMANIZED MONOCLONAL ANTIBODY BLOCKING IL1Α, IL1Β, IL36 SIMULTANEOUSLY, BY TARGETING THE EXTRACELLULAR DOMAIN OF IL1RAP.

GM • Nov. 4, 2025

GOLD RESOURCE CORPORATION REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025

DENVER--(BUSINESS WIRE)--GOLD RESOURCE CORPORATION (NYSE AMERICAN: GORO) (THE “COMPANY”) IS PLEASED TO ANNOUNCE ITS THIRD QUARTER OPERATIONAL RESULTS FROM ITS DON DAVID GOLD MINE (“DDGM”) NEAR OAXACA, MEXICO. “I'M PLEASED TO REPORT THAT WE ARE BEGINNING TO SEE ENCOURAGING SIGNS OF A TURNAROUND AT THE DON DAVID GOLD MINE IN MEXICO,” SAID ALLEN PALMIERE, PRESIDENT AND CEO. “WE'VE STARTED RECEIVING SOME OF THE GENTLY USED EQUIPMENT THAT WE ORDERED, AND IT IS ALREADY OPERATIONAL WITHIN THE MINE. DE.

GORO • Nov. 4, 2025

PENNANT ACQUIRES SENIOR LIVING COMMUNITIES IN IDAHO AND WISCONSIN

EAGLE, IDAHO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- THE PENNANT GROUP, INC. (NASDAQ: PNTG), THE PARENT COMPANY OF THE PENNANT GROUP OF AFFILIATED HOME HEALTH, HOSPICE, HOME CARE AND SENIOR LIVING COMPANIES, ANNOUNCES TWO SIGNIFICANT ACQUISITIONS THAT STRENGTHEN ITS PRESENCES IN KEY MARKETS.

PNTG • Nov. 4, 2025

AURA ANNOUNCES Q3 2025 AND 9M 2025 FINANCIAL AND OPERATIONAL RESULTS

ROAD TOWN, BRITISH VIRGIN ISLANDS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- AURA MINERALS INC. (NASDAQ: AUGO) (B3: AURA33) (“AURA” OR THE “COMPANY”) ANNOUNCES THAT IT HAS FILED ITS AUDITED CONSOLIDATED FINANCIAL STATEMENTS AND EARNINGS RELEASE (TOGETHER, “FINANCIAL AND OPERATIONAL RESULTS”) FOR THE PERIOD ENDED SEPTEMBER 30, 2025. THE FULL VERSION OF THE FINANCIAL AND OPERATIONAL RESULTS CAN BE VIEWED ON THE COMPANY'S WEBSITE AT WWW.AURAMINERALS.COM, ON SEDAR+ AT WWW.SEDARPLUS.CA.

ORAAF • Nov. 4, 2025

NABORS COMMENTS ON UPGRADES TO CREDIT RATINGS

HAMILTON, BERMUDA , NOV. 4, 2025 /PRNEWSWIRE/ -- NABORS INDUSTRIES LTD. ("NABORS" OR THE "COMPANY") (NYSE: NBR) TODAY COMMENTED ON THE RECENT CREDIT RATINGS ACTIONS TAKEN BY ALL THREE OF THE MAJOR CREDIT RATING AGENCIES.

NBR • Nov. 4, 2025

EXZEO GROUP, INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

TAMPA, FLA.--(BUSINESS WIRE)--EXZEO GROUP, INC. (NYSE:XZO) TODAY ANNOUNCED THE PRICING OF ITS INITIAL PUBLIC OFFERING (“IPO”) OF 8,000,000 SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING PRICE OF $21.00. ALL SHARES BEING OFFERED ARE BEING SOLD BY EXZEO. IN ADDITION, EXZEO HAS GRANTED THE UNDERWRITERS A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL 1,200,000 COMMON SHARES AT THE IPO PRICE, LESS UNDERWRITING DISCOUNTS AND COMMISSIONS. THE SHARES ARE EXPECTED TO BEGIN TRADING ON THE NEW YORK STOCK.

XZO • Nov. 4, 2025

MESOBLAST TO MEET WITH FDA NEXT MONTH TO DISCUSS REXLEMESTROCEL-L AND OPIOID CESSATION

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- MESOBLAST LIMITED (NASDAQ:MESO; ASX:MSB), GLOBAL LEADER IN ALLOGENEIC CELLULAR MEDICINES FOR INFLAMMATORY DISEASES, TODAY ANNOUNCED THAT THE U.S. FOOD & DRUG ADMINISTRATION (FDA) HAS SCHEDULED A MEETING IN EARLY DECEMBER TO DISCUSS MESOBLAST'S DATA ON OPIOID REDUCTION AND CESSATION FROM ITS FIRST PHASE 3 STUDY (MSB-DR003) OF REXLEMESTROCEL-L IN PATIENTS WITH CHRONIC LOW BACK PAIN (CLBP).

MESO • Nov. 4, 2025

CARMAX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH SUBSTANTIAL LOSSES OF LEAD PLAINTIFF DEADLINE IN CLASS ACTION LAWSUIT AGAINST CARMAX, INC. - KMX

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS WITH SUBSTANTIAL LOSSES THAT THEY HAVE UNTIL JANUARY 2, 2026 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST CARMAX, INC. (NYSE: KMX), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN JUNE 20, 2025 AND SEPTEMBER 24, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION I.

KMX • Nov. 4, 2025

WAL INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN WESTERN ALLIANCE BANCORPORATION (NYSE: WAL), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF WESTERN ALLIANCE BANCORPORATION (NYSE: WAL) RESULTING FROM ALLEGATIONS THAT WESTERN ALLIANCE BANCORPORATION MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.

WAL • Nov. 4, 2025

NABORS PRICES $700 MILLION IN SENIOR PRIORITY GUARANTEED NOTES

HAMILTON, BERMUDA , NOV. 4, 2025 /PRNEWSWIRE/ -- NABORS INDUSTRIES LTD. (NYSE: NBR) ("NABORS") TODAY ANNOUNCED THAT NABORS INDUSTRIES, INC. ("NII") HAS PRICED $700 MILLION IN AGGREGATE PRINCIPAL AMOUNT OF SENIOR PRIORITY GUARANTEED NOTES DUE 2032 (THE "NOTES").

NBR • Nov. 4, 2025

AURA DECLARES DIVIDEND OF US$0.48 PER SHARE AND US$0.16 PER BDR BASED ON Q3 2025 RESULTS, RESULTING IN A DIVIDEND YIELD OF 7.4% IN THE LTM

ROAD TOWN, BRITISH VIRGIN ISLANDS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- AURA MINERALS INC. (NASDAQ: AUGO) (B3: AURA33) (“AURA” OR THE “COMPANY”) ANNOUNCED TODAY THAT THE COMPANY'S BOARD OF DIRECTORS (THE “BOARD”) HAS DECLARED AND APPROVED THE PAYMENT OF A DIVIDEND (THE “DIVIDEND”) OF US$0.48 PER COMMON SHARE (APPROXIMATELY US$ 40.1 2 MILLION IN TOTAL). THIS PAYMENT IS ABOVE THE MINIMUM FORESEEN IN THE COMPANY'S DIVIDEND POLICY (THE “DIVIDEND POLICY”).

BDR • Nov. 4, 2025

FORGE GLOBAL HOLDINGS, INC. TO REPORT THIRD QUARTER FISCAL 2025 FINANCIAL RESULTS ON NOVEMBER 14, 2025

SAN FRANCISCO--(BUSINESS WIRE)--FORGE GLOBAL HOLDINGS, INC. (“FORGE”) (NYSE: FRGE), A LEADING PROVIDER OF MARKETPLACE INFRASTRUCTURE, DATA SERVICES, AND TECHNOLOGY AND INVESTMENT SOLUTIONS FOR THE PRIVATE MARKET, TODAY ANNOUNCED THAT IT WILL REPORT ITS THIRD QUARTER FISCAL 2025 FINANCIAL RESULTS ON NOVEMBER 14, 2025. ABOUT FORGE FORGE (NYSE: FRGE) IS A LEADING PROVIDER OF MARKETPLACE INFRASTRUCTURE, DATA SERVICES AND TECHNOLOGY AND INVESTMENT SOLUTIONS FOR THE PRIVATE MARKET. FORGE SECURITIES L.

FIGP • Nov. 4, 2025

WAYFAIR PRICES OFFERING OF $700 MILLION SENIOR SECURED NOTES

BOSTON , NOV. 4, 2025 /PRNEWSWIRE/ -- WAYFAIR INC. (NYSE: W) (THE "COMPANY," "WE" OR "WAYFAIR") TODAY ANNOUNCED THE PRICING BY ITS SUBSIDIARY, WAYFAIR LLC (THE "ISSUER"), OF ITS PRIVATE OFFERING OF $700 MILLION IN AGGREGATE PRINCIPAL AMOUNT OF 6.75% SENIOR SECURED NOTES DUE 2032 (THE "NOTES"). THE NOTES WILL MATURE ON NOVEMBER 15, 2032, UNLESS EARLIER REPURCHASED OR REDEEMED IN ACCORDANCE WITH THEIR TERMS.

W • Nov. 4, 2025

STRIDE, INC. (LRN) PLUNGES 49% AS PLATFORM UPGRADE FAILS, TRIGGERING HAGENS BERMAN PROBE -- HAGENS BERMAN

SAN FRANCISCO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- PROMINENT SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN IS INVESTIGATING STRIDE, INC. (NYSE: LRN), THE ONLINE EDUCATION PLATFORM, FOR POTENTIAL VIOLATIONS OF THE U.S. SECURITIES LAWS FOLLOWING A SERIES OF NEGATIVE MARKET EVENTS AND SERIOUS FRAUD ALLEGATIONS THAT HAVE SEEN THE COMPANY'S STOCK PRICE PLUMMET. THE FIRM URGES INVESTORS IN STRIDE WHO SUFFERED SIGNIFICANT LOSSES TO SUBMIT YOUR LOSSES NOW.

LRN • Nov. 4, 2025

ROSEN, LEADING INVESTOR RIGHTS COUNSEL, ENCOURAGES SINA CORPORATION INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION - SINA

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS SELLERS OF ORDINARY SHARES, INCLUDING THOSE THAT SOLD INTO THE MERGER OF SINA CORPORATION (NASDAQ: SINA) BETWEEN OCTOBER 13, 2020 AND MARCH 22, 2021, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 18, 2025 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION.

SINA • Nov. 4, 2025

DUNDEE CORPORATION ANNOUNCES EXERCISE OF WARRANTS IN MAGNA MINING INC.

TORONTO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- IN ACCORDANCE WITH REGULATORY REQUIREMENTS, DUNDEE CORPORATION (TSX: DC.A) (“DUNDEE” OR THE “CORPORATION”) ANNOUNCES THAT IT HAS EXERCISED 4,259,259 WARRANTS OF MAGNA MINING INC. (THE “ISSUER”) AT AN EXERCISE PRICE OF $0.405 PER WARRANT. EACH WARRANT WAS EXERCISABLE FOR ONE COMMON SHARE OF THE ISSUER.

DDEJF • Nov. 4, 2025

KMX ALERT: KIRBY MCINERNEY LLP ANNOUNCES THE FILING OF A SECURITIES CLASS ACTION ON BEHALF OF CARMAX, INC. INVESTORS

NEW YORK--(BUSINESS WIRE)---- $KMX #CLASSACTIONLAWSUIT--THE LAW FIRM OF KIRBY MCINERNEY LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT - JASON CAP V. CARMAX, INC. - HAS BEEN FILED ON BEHALF OF INVESTORS WHO ACQUIRED CARMAX, INC. (“CARMAX” OR THE “COMPANY”) (NYSE:KMX) SECURITIES DURING THE PERIOD OF JUNE 20, 2025 THROUGH SEPTEMBER 24, 2025, INCLUSIVE (“THE CLASS PERIOD”). IF YOU SUFFERED A LOSS ON YOUR CARMAX INVESTMENTS, YOU HAVE UNTIL JANUARY 2, 2026 TO REQUEST LEAD PLAINTIFF APPOINTMENT. FOR MORE INFORMATION: [CONTACT THE FIR.

KMX • Nov. 4, 2025

AM BEST COMMENTS ON CREDIT RATINGS OF PALOMAR HOLDINGS, INC., ITS MEMBER COMPANIES AND AFFILIATE

OLDWICK, N.J.--(BUSINESS WIRE)--AM BEST HAS COMMENTED THAT THE CREDIT RATINGS (RATINGS) OF PALOMAR HOLDINGS, INC. (PALOMAR) (DELAWARE) [NASDAQ: PLMR], THE ULTIMATE PARENT AND INSURANCE HOLDING COMPANY OF PALOMAR SPECIALTY INSURANCE COMPANY (PSIC) (PORTLAND, OR), PALOMAR EXCESS AND SURPLUS INSURANCE COMPANY (PESIC) (PHOENIX, AZ), PALOMAR SPECIALTY REINSURANCE COMPANY BERMUDA LTD. (PALOMAR RE) (BERMUDA) AND FIRST INDEMNITY OF AMERICA INSURANCE COMPANY (FIA) (MORRIS PLAINS, NJ) REMAIN UNCHANGED FO.

PLMR • Nov. 4, 2025

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF FIRST FOUNDATION INC. (NYSE: FFWM)

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING FIRST FOUNDATION INC. (NYSE: FFWM ) RELATED TO ITS SALE TO FIRSTSUN CAPITAL BANCORP. UNDER THE TERMS OF THE PROPOSED TRANSACTION, FIRST FOUNDATION SHAREHOLDERS WILL RECEIVE 0.16083 OF A SHARE OF FIRSTSUN COMMON STOCK FOR EACH FIRST FOUNDATION COMMON STOCK. IS IT A FAIR DEAL?

FFWM • Nov. 4, 2025

UNIQURE N.V. INVESTIGATION: KIRBY MCINERNEY LLP ANNOUNCES INVESTIGATION INTO POTENTIAL SECURITIES FRAUD ON BEHALF OF INVESTORS (QURE)

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- THE LAW FIRM OF KIRBY MCINERNEY LLP IS INVESTIGATING POTENTIAL CLAIMS AGAINST UNIQURE N.V. (“UNIQURE” OR THE “COMPANY”) (NASDAQ:QURE). THE INVESTIGATION CONCERNS WHETHER THE COMPANY AND/OR MEMBERS OF ITS SENIOR MANAGEMENT MAY HAVE VIOLATED FEDERAL SECURITIES LAWS OR ENGAGED IN OTHER UNLAWFUL BUSINESS PRACTICES.

QURE • Nov. 4, 2025

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF SM ENERGY COMPANY (NYSE: SM)

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY  JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING SM ENERGY COMPANY (NYSE: SM ) RELATED TO ITS MERGER WITH CIVITAS RESOURCES, INC. UPON COMPLETION OF THE PROPOSED TRANSACTION, SM ENERGY SHAREHOLDERS WILL OWN APPROXIMATELY 48% OF THE COMBINED COMPANY. IS IT A FAIR DEAL?

SM • Nov. 4, 2025

ENTRÉE RESOURCES ANNOUNCES THIRD QUARTER 2025 RESULTS

VANCOUVER, BRITISH COLUMBIA, NOV. 04, 2025 (GLOBE NEWSWIRE) -- ENTRÉE RESOURCES LTD. (TSX:ETG; OTCQB:ERLFF – THE “COMPANY” OR “ENTRÉE”) HAS TODAY FILED ITS INTERIM FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025.

ERLFF • Nov. 4, 2025

CLEARFIELD SETS FISCAL FOURTH QUARTER 2025 EARNINGS CALL FOR TUESDAY, NOVEMBER 25, 2025

MINNEAPOLIS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLEARFIELD, INC. (NASDAQ: CLFD), THE LEADER IN COMMUNITY BROADBAND FIBER CONNECTIVITY, TODAY ANNOUNCED THAT IT WILL RELEASE RESULTS FOR THE FOURTH QUARTER OF FISCAL 2025, ENDED SEPTEMBER 30, 2025, ON TUESDAY, NOVEMBER 25, 2025, BEFORE THE MARKET OPEN. THE COMPANY WILL HOST A CONFERENCE CALL AT 8:30 A.M. EASTERN TIME (7:30 A.M. CENTRAL TIME) TO DISCUSS ITS FINANCIAL RESULTS WITH THE INVESTMENT COMMUNITY.

CLFD • Nov. 4, 2025

ERDENE ANNOUNCES Q3 2025 RESULTS PROVIDES BAYAN KHUNDII MINING AND EXPLORATION UPDATE

HIGHLIGHTS: PRODUCED FIRST GOLD AT BAYAN KHUNDII ON SEPTEMBER 14 AND EXPECT TO ACHIEVE NAMEPLATE PRODUCTION BY END OF 2025 ANNOUNCED UPDATED INDEPENDENT MINERAL RESOURCE ESTIMATE FOR ZUUN MOD MOLYBDENUM-COPPER PORPHYRY PROJECT ENTERED OPTION AGREEMENT TO ACQUIRE UP TO 80% OF THE TEREG UUL COPPER-GOLD PORPHYRY PROSPECT HALIFAX, NOVA SCOTIA, NOV. 04, 2025 (GLOBE NEWSWIRE) -- ERDENE RESOURCE DEVELOPMENT CORP. (TSX:ERD; MSE:ERDN; OTCQB: ERFCF) ("ERDENE" OR THE "COMPANY") IS PLEASED TO ANNOUNCE OPERATING AND FINANCIAL RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025, AND TO PROVIDE AN UPDATE ON THE BAYAN KHUNDII GOLD MINE (“BK”), OPERATED BY ERDENE MONGOL LLC (“EM”), THE COMPANY'S JOINT VENTURE WITH MONGOLIAN MINING CORPORATION (“MMC”). THIS RELEASE SHOULD BE READ IN CONJUNCTION WITH THE COMPANY'S Q3 2025 FINANCIAL STATEMENTS AND MD&A, AVAILABLE ON THE COMPANY'S WEBSITE AND SEDAR+.

ERDCF • Nov. 4, 2025

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF COEUR MINING, INC. (NYSE: CDE)

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING COEUR MINING, INC. (NYSE: CDE ) RELATED TO ITS MERGER WITH NEW GOLD, INC. UPON COMPLETION OF THE PROPOSED TRANSACTION, COEUR SHAREHOLDERS WILL OWN APPROXIMATELY 62% OF THE COMBINED COMPANY. IS IT A FAIR DEAL?

CDE • Nov. 4, 2025

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF EVOKE PHARMA, INC. (NASDAQ: EVOK)

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING EVOKE PHARMA, INC. (NASDAQ: EVOK ) RELATED TO ITS SALE TO QOL MEDICAL, LLC. UNDER THE TERMS OF THE PROPOSED TRANSACTION, EVOKE SHAREHOLDERS WILL RECEIVE $11.00 PER SHARE IN CASH. IS IT A FAIR DEAL?

EVOK • Nov. 4, 2025

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF DENNY'S CORPORATION (NASDAQ: DENN)

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING DENNY'S CORPORATION (NASDAQ: DENN ) RELATED TO ITS SALE TO GROUP CONSISTING OF TRIARTISAN CAPITAL ADVISORS LLC, TREVILLE CAPITAL GROUP, AND YADAV ENTERPRISES, INC. UNDER THE TERMS OF THE PROPOSED TRANSACTION, DENNY'S SHAREHOLDERS WILL RECEIVE $6.25 PER SHARE IN CASH. IS IT A FAIR DEAL?

DENN • Nov. 4, 2025

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF KENVUE INC. (NYSE: KVUE)

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY  JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING KENVUE INC. (NYSE:  KVUE ) RELATED TO ITS SALE TO KIMBERLY-CLARK CORPORATION. UNDER THE TERMS OF THE PROPOSED TRANSACTION, KENVUE SHAREHOLDERS WILL RECEIVE $3.50 PER SHARE IN CASH PLUS 0.14625 KIMBERLY-CLARK SHARES FOR EACH KENVUE SHARE. IS IT A FAIR DEAL?

KVUE • Nov. 4, 2025

JHX: KIRBY MCINERNEY LLP ADVISES JAMES HARDIE INDUSTRIES PLC INVESTORS OF CLASS ACTION LAWSUIT

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KIRBY MCINERNEY LLP REMINDS INVESTORS WHO PURCHASED JAMES HARDIE INDUSTRIES PLC (“JAMES HARDIE” OR THE “COMPANY”) (NYSE:JHX) SECURITIES TO CONTACT THOMAS W. ELROD OF KIRBY MCINERNEY LLP BY EMAIL AT [email protected], OR FILL OUT THE CONTACT FORM BELOW, TO DISCUSS YOUR RIGHTS OR INTERESTS IN THE SECURITIES FRAUD CLASS ACTION LAWSUIT AT NO COST.

JHX • Nov. 4, 2025

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF KIMBERLY-CLARK CORPORATION (NASDAQ: KMB)

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING KIMBERLY-CLARK CORPORATION (NASDAQ: KMB ) RELATED TO ITS MERGER WITH KENVUE INC. UPON COMPLETION OF THE PROPOSED TRANSACTION, KIMBERLY-CLARK SHAREHOLDERS ARE EXPECTED TO OWN APPROXIMATELY 54% OF THE COMBINED COMPANY. IS IT A FAIR DEAL?

KMB • Nov. 4, 2025

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF CIVITAS RESOURCES, INC. (NYSE: CIVI)

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY  JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING CIVITAS RESOURCES, INC. (NYSE: CIVI ) RELATED TO ITS SALE TO SM ENERGY COMPANY. UNDER THE TERMS OF THE PROPOSED TRANSACTION, CIVITAS SHAREHOLDERS WILL RECEIVE 1.45 SHARES OF SM ENERGY COMMON STOCK PER SHARE OF CIVITAS. IS IT A FAIR DEAL?

CIVI • Nov. 4, 2025

AMERICAN BANK HOLDING CORPORATION SHAREHOLDERS APPROVE ACQUISITION BY PROSPERITY BANCSHARES, INC.®

HOUSTON AND CORPUS CHRISTI, TEXAS , NOV. 4, 2025 /PRNEWSWIRE/ -- PROSPERITY BANCSHARES, INC.® (NYSE: PB) ("PROSPERITY"), THE PARENT COMPANY OF PROSPERITY BANK®, AND AMERICAN BANK HOLDING CORPORATION ("AMERICAN"), THE PARENT HOLDING COMPANY OF AMERICAN BANK, N.A. ("AMERICAN BANK"), HEADQUARTERED IN CORPUS CHRISTI, TEXAS, TODAY JOINTLY ANNOUNCED THAT THE SHAREHOLDERS OF AMERICAN HAVE APPROVED THE PREVIOUSLY ANNOUNCED PROPOSED MERGER OF AMERICAN WITH AND INTO PROSPERITY, WITH PROSPERITY CONTINUING AS THE SURVIVING CORPORATION, TO BE FOLLOWED BY THE PROPOSED MERGER OF AMERICAN BANK WITH AND INTO PROSPERITY BANK.

PB • Nov. 4, 2025

WOODSIDE ENERGY CAPITAL MARKETS DAY 2025

PERTH, AUSTRALIA--(BUSINESS WIRE)--AT ITS 2025 CAPITAL MARKETS DAY TODAY, WOODSIDE OUTLINED ITS STRATEGY TO THRIVE THROUGH THE ENERGY TRANSITION AND DELIVER LONG-TERM SHAREHOLDER VALUE BY MEETING RISING GLOBAL DEMAND FOR AFFORDABLE, RELIABLE, LOWER-CARBON ENERGY. CHIEF EXECUTIVE OFFICER MEG O'NEILL SAID SHE IS EXCITED BY THE OPPORTUNITIES AHEAD OF WOODSIDE. “WOODSIDE IS A COMPELLING INVESTMENT OPPORTUNITY SUPPORTED BY WORLD-CLASS ASSETS, AN INTEGRATED VALUE CHAIN, LONG-TERM CUSTOMER RELATIONSHI.

WDS • Nov. 4, 2025

FISERV, INC. (FI) FACES SECURITIES CLASS ACTION AMID “‘ABYSMAL'” Q3 2025 RESULTS, ADMITS OBJECTIVELY DIFFICULT-TO-ACHIEVE JULY 2025 GUIDANCE ASSUMPTIONS – HAGENS BERMAN

SAN FRANCISCO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- A SECURITIES FRAUD CLASS ACTION STYLED CYPANGA SICAV SIF V. FISERV, INC., ET AL., NO. 2:25-CV-01716 (E.D. WIS.), HAS BEEN FILED IN THE WAKE OF A 47% CRASH IN THE PRICE OF FISERV, INC. (NYSE: FI) SHARES ON THE COMPANY'S Q3 2025 FINANCIAL RESULTS AND DRAMATICALLY REDUCED GUIDANCE.

FI • Nov. 4, 2025

ROSEN LAW FIRM ENCOURAGES HORMEL FOODS CORPORATION INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - HRL

NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES AN INVESTIGATION OF POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF HORMEL FOODS CORPORATION (NYSE: HRL) RESULTING FROM ALLEGATIONS THAT HORMEL MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC. SO WHAT: IF YOU PURCHASED HORMEL SECURITIES YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.

HRL • Nov. 4, 2025

DORCHESTER MINERALS, L.P. ANNOUNCES THE PASSING OF C.W.

DALLAS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- DORCHESTER MINERALS, L.P. (THE “PARTNERSHIP”) (NASDAQ-DMLP) MOURNS THE PASSING OF C.W. “BILL” RUSSELL, A DEDICATED MEMBER OF OUR BOARD OF MANAGERS AND ADVISORY COMMITTEE SINCE 2004, AND CHAIRMAN OF THE AUDIT COMMITTEE.

MTX • Nov. 4, 2025

ELAUWIT ANNOUNCES PRICING OF $15.0 MILLION INITIAL PUBLIC OFFERING

COLUMBIA, SOUTH CAROLINA--(NEWSFILE CORP. - NOVEMBER 4, 2025) - ELAUWIT CONNECTION, INC. ("ELAUWIT" OR THE "COMPANY") TODAY ANNOUNCED THE PRICING OF ITS FIRM COMMITMENT INITIAL PUBLIC OFFERING OF AN AGGREGATE OF 1,667,000 SHARES OF ITS COMMON STOCK (THE "OFFERING") AT $9.00 PER SHARE. THE GROSS PROCEEDS TO ELAUWIT FROM THE OFFERING, BEFORE DEDUCTING UNDERWRITING DISCOUNTS AND COMMISSIONS AND ESTIMATED OFFERING EXPENSES PAYABLE BY ELAUWIT, ARE EXPECTED TO BE APPROXIMATELY $15.0 MILLION WITHOUT THE EXERCISE OF THE UNDERWRITERS' OVER-ALLOTMENT OPTION.

ELWT • Nov. 4, 2025

KORE ANNOUNCES RECEIPT OF NON-BINDING LETTER RELATING TO ACQUISITION OF COMMON STOCK

ATLANTA , NOV. 4, 2025 /PRNEWSWIRE/ -- KORE GROUP HOLDINGS, INC. (NYSE: KORE) ("KORE" OR THE "COMPANY")), THE GLOBAL PURE-PLAY INTERNET OF THINGS ("IOT") HYPERSCALER AND LEADING PROVIDER OF IOT CONNECTIVITY, SOLUTIONS, AND ANALYTICS, TODAY ANNOUNCED THAT A SPECIAL COMMITTEE (THE "COMMITTEE") OF THE BOARD OF DIRECTORS (THE "BOARD") OF THE COMPANY RECEIVED A NON-BINDING LETTER (THE "LETTER") FROM SEARCHLIGHT CAPITAL PARTNERS, L.P., ON BEHALF OF ITS AFFILIATED INVESTMENT FUNDS (COLLECTIVELY, "SEARCHLIGHT"), AND ABRY PARTNERS, LLC, ON BEHALF OF ITS AFFILIATED INVESTMENT FUNDS (COLLECTIVELY, "ABRY"), TO ENTER INTO DISCUSSIONS TO ACQUIRE ALL OF THE OUTSTANDING SHARES OF COMMON STOCK (THE "COMMON STOCK") OF THE COMPANY NOT ALREADY OWNED BY SEARCHLIGHT OR ABRY FOR CASH CONSIDERATION OF $5.00 PER SHARE.

KORE • Nov. 4, 2025

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, ENCOURAGES CEPTON, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION – CPTN

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OR SELLERS OF COMMON STOCK OF CEPTON, INC. (NASDAQ: CPTN) BETWEEN JULY 29, 2024 AND JANUARY 6, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT DECEMBER 8, 2025 LEAD PLAINTIFF DEADLINE.

CPTN • Nov. 4, 2025

BRAGAR EAGEL & SQUIRE, P.C. REMINDS INVESTORS OF BAXTER, SPIRIT AVIATION, AND MOLINA TO CONTACT THE FIRM ABOUT THEIR RIGHTS IN FILED CLASS ACTION LAWSUITS

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- BRAGAR EAGEL & SQUIRE, P.C., A NATIONALLY RECOGNIZED SHAREHOLDER RIGHTS LAW FIRM, REMINDS INVESTORS THAT CLASS ACTIONS HAVE BEEN COMMENCED ON BEHALF OF STOCKHOLDERS OF BAXTER INTERNATIONAL, INC. (NYSE:BAX), SPIRIT AVIATION HOLDINGS, INC. (OTCMKTS:FLYYQ), AND MOLINA HEALTHCARE, INC. (NYSE: MOH). STOCKHOLDERS HAVE UNTIL THE DEADLINES BELOW TO PETITION THE COURT TO SERVE AS LEAD PLAINTIFF. ADDITIONAL INFORMATION ABOUT EACH CASE CAN BE FOUND AT THE LINK PROVIDED.

MOH • Nov. 4, 2025

FLR DEADLINE: FLR INVESTORS WITH LOSSES IN EXCESS OF $100K HAVE OPPORTUNITY TO LEAD FLUOR CORPORATION SECURITIES FRAUD LAWSUIT

NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF FLUOR CORPORATION (NYSE: FLR) BETWEEN FEBRUARY 18, 2025 AND JULY 31, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 14, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED FLUOR SECURITIES DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.

FLR • Nov. 4, 2025

DENTALCORP ANNOUNCES RECEIPT OF INTERIM ORDER AND UPDATE REGARDING PROPOSED ACQUISITION BY INVESTMENT FUNDS AFFILIATED WITH GTCR

TORONTO--(BUSINESS WIRE)--DENTALCORP HOLDINGS LTD. (“DENTALCORP” OR THE “COMPANY”) (TSX: DNTL), CANADA'S LARGEST AND ONE OF NORTH AMERICA'S FASTEST GROWING NETWORKS OF DENTAL PRACTICES, TODAY ANNOUNCED THAT THE SUPREME COURT OF BRITISH COLUMBIA HAS GRANTED DENTALCORP AN INTERIM ORDER PROVIDING FOR THE CALLING AND HOLDING OF THE SPECIAL MEETING OF DENTALCORP SECURITYHOLDERS TO BE HELD ON DECEMBER 4, 2025 AT 11:00 A.M. (TORONTO TIME) (THE “SECURITYHOLDER MEETING”) AND ADDRESSING OTHER PROCEDURAL.

DNTL • Nov. 4, 2025

BOARDWALK REIT REPORTS STRONG RESULTS FOR Q3 2025

CALGARY, AB , NOV. 4, 2025 /PRNEWSWIRE/ - BOARDWALK REAL ESTATE INVESTMENT TRUST (TSX: BEI.UN) SUMMARY HIGHLIGHTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025 STRONG FINANCIAL PERFORMANCE FOR THE 3 MONTH PERIOD ENDED SEPTEMBER 30, 2025 FUNDS FROM OPERATIONS ("FFO") OF $1.23 PER UNIT(1)(2); AN INCREASE OF 10.8% FROM Q3 2024 PROFIT OF $37.6 MILLION NET OPERATING INCOME ("NOI") OF $108.3 MILLION; AN INCREASE OF 8.1% FROM Q3 2024 SAME PROPERTY(3) NET OPERATING INCOME ("SAME PROPERTY NOI") OF $105.3 MILLION; AN INCREASE OF 8.6% FROM Q3 2024 OPERATING MARGIN OF 67.4%; AN INCREASE OF 210 BASIS POINTS ("BPS") FROM Q3 2024           FOR THE 9 MONTH PERIOD ENDED SEPTEMBER 30, 2025 FUNDS FROM OPERATIONS ("FFO") OF $3.45 PER UNIT(1)(2); AN INCREASE OF 11.3% FROM THE SAME PERIOD A YEAR AGO PROFIT OF $247.7 MILLION NET OPERATING INCOME ("NOI") OF $309.1 MILLION; AN INCREASE OF 9.1% FROM THE SAME PERIOD A YEAR AGO SAME PROPERTY(3) NET OPERATING INCOME ("SAME PROPERTY NOI") OF $302.7 MILLION; AN INCREASE OF 9.6% FROM THE SAME PERIOD A YEAR AGO OPERATING MARGIN OF 65.2%; AN INCREASE OF 190 BPS FROM THE SAME PERIOD A YEAR AGO SAME PROPERTY RENTAL REVENUE GROWTH IN Q3 2025 Q3 2025 SAME PROPERTY SEQUENTIAL QUARTERLY RENTAL REVENUE GROWTH OF 1.4% FROM THE PRIOR QUARTER, EXCLUDING BRIO WHICH THE TRUST CLOSED ON THE PURCHASE OF THE REMAINING 50% INTEREST IN AUGUST Q3 2025 SAME PROPERTY RENTAL REVENUE GROWTH OF 5.0% FROM A YEAR AGO, EXCLUDING BRIO OCCUPANCY OF 97.7% IN Q3 2025 AFFORDABLE REGIONS AND COMMUNITIES REMAIN IN HIGH DEMAND POPULATION GROWTH CONTINUES TO FAVOR ALBERTA, QUEBEC, AND SASKATCHEWAN ON A RELATIVE BASIS RENTS IN EDMONTON, THE TRUST'S LARGEST MARKET, REMAIN SOME OF THE MOST AFFORDABLE AMONGST MAJOR CITIES IN CANADA THE TRUST HAS CUMULATIVELY RE-INVESTED IN COMMON AREA IMPROVEMENTS REPRESENTING APPROXIMATELY 77% OF ITS PORTFOLIO SINCE 2017, IMPROVING PORTFOLIO QUALITY AND RESILIENCE ACROSS MARKET CONDITIONS STRONG AND FLEXIBLE BALANCE SHEET APPROXIMATELY $379.6 MILLION OF TOTAL AVAILABLE LIQUIDITY AT THE END OF THE QUARTER 96% OF BOARDWALK'S MORTGAGES CARRY CMHC-INSURANCE UNITHOLDERS' EQUITY OF $5.0 BILLION FAIR VALUE CAPITALIZATION RATE OF 5.12%, CONSISTENT WITH Q4 2024 NET ASSET VALUE INCREASE TO $97.72 PER UNIT(1)(2), PRIMARILY A RESULT OF HIGHER RENTAL RATES IN THE TRUST'S MORE AFFORDABLE MARKETS DEBT TO EBITDA(1) OF 10.09X, COMPARED TO 10.08X FOR THE YEAR ENDED DECEMBER 31, 2024 DEBT TO TOTAL ASSETS(1) OF 41.4%, COMPARED TO 40.6% AS AT DECEMBER 31, 2024 DEBT INCREASED MARGINALLY DURING THE QUARTER TO CAPITALIZE ON OPPORTUNISTIC ACCRETIVE EXTERNAL GROWTH OPPORTUNITIES UPDATE TO 2025 FINANCIAL GUIDANCE  REVISED FFO RANGE OF $4.58 TO $4.65 PER UNIT(1)(2) SAME PROPERTY NOI GROWTH RANGE OF +8.5% TO +10.0% STRATEGIC CAPITAL ALLOCATION DURING THE QUARTER, CLOSED ON PREVIOUSLY ANNOUNCED ACQUISITIONS IN SASKATOON, REGINA, CALGARY AND LAVAL TOTALING $419.5 MILLION AND DISPOSITIONS IN EDMONTON AND QUÉBEC CITY TOTALING $141.2 MILLION ANNOUNCED 639 MAIN STREET ACQUISITION IN SASKATOON SUBSEQUENTLY TO QUARTER END FOR $39.0 MILLION YEAR-TO-DATE, HAVE INVESTED $36.8 MILLION INTO THE REPURCHASE AND CANCELLATION OF 576,983 TRUST UNITS AT A WEIGHTED AVERAGE PRICE OF $63.79 $6.0 MILLION (INCLUDED IN $36.8 MILLION ABOVE) DEPLOYED SUBSEQUENTLY TO QUARTER END AT A WEIGHTED AVERAGE PRICE OF $66.51; MANAGEMENT PRIORITIZING UNIT REPURCHASES AT CURRENT UNIT PRICE LEVEL EXCEPTIONAL VALUE AT CURRENT UNIT PRICE OF APPROXIMATELY $64, BOARDWALK'S IMPLIED VALUE IS APPROXIMATELY $188,000 PER SUITE, EQUATING TO AN ATTRACTIVE 6.4% CAP RATE ON TRAILING NOI, WITH SIGNIFICANT GROWTH REFLECTED IN UPDATED GUIDANCE ABOVE REGULAR DISTRIBUTION OF $1.62 PER TRUST UNIT ON AN ANNUALIZED BASIS CONFIRMED FOR THE MONTHS OF DECEMBER 2025, JANUARY 2026 AND FEBRUARY 2026 (1) PLEASE REFER TO THE SECTION TITLED "PRESENTATION OF NON-GAAP MEASURES" IN THIS NEWS RELEASE FOR MORE INFORMATION. (2) BOARDWALK REIT'S UNITS (THE "TRUST UNITS") TRADE ON THE TORONTO STOCK EXCHANGE ("TSX") UNDER THE TRADING SYMBOL 'BEI.UN'.

UNTC • Nov. 4, 2025

WESTBOND REPORTS FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025

DELTA, BRITISH COLUMBIA, NOV. 04, 2025 (GLOBE NEWSWIRE) -- WESTBOND ENTERPRISES CORPORATION (TSX-V: WBE) IS PLEASED TO ANNOUNCE THAT THE NET PROFIT FOR THE QUARTER ENDED SEPTEMBER 30, 2025 INCREASED 79% TO $174,630 WHEN COMPARED TO A PROFIT OF $97,710 FOR THE THREE MONTHS ENDED JUNE 30, 2025. SALES WERE $3,030,669 FOR THE QUARTER ENDED SEPTEMBER 30, 2025, WHICH IS 11.1% HIGHER THAN $2,727,414 FOR THE QUARTER ENDED JUNE 30, 2025.

WBNEF • Nov. 4, 2025

UNIVEST SECURITIES, LLC ANNOUNCES CLOSING OF $4.2 MILLION REGISTERED DIRECT OFFERING FOR ITS CLIENT BOQII HOLDING LTD. (NYSE: BQ)

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- UNIVEST SECURITIES, LLC (“UNIVEST”), A MEMBER OF FINRA AND SIPC, AND A FULL-SERVICE INVESTMENT BANK AND SECURITIES BROKER-DEALER FIRM BASED IN NEW YORK, TODAY ANNOUNCED THE CLOSING OF A REGISTERED DIRECT OFFERING (THE “OFFERING”) OF APPROXIMATELY $4.2 MILLION FOR ITS CLIENT BOQII HOLDING LIMITED (NYSE: BQ) (THE “COMPANY” OR “BOQII”), A LEADING PET-FOCUSED PLATFORM IN CHINA.

BQ • Nov. 4, 2025

MEDEXUS SCHEDULES SECOND FISCAL QUARTER 2026 CONFERENCE CALL

TORONTO, ONTARIO AND CHICAGO, ILLINOIS--(NEWSFILE CORP. - NOVEMBER 4, 2025) - MEDEXUS PHARMACEUTICALS (TSX: MDP) (OTCQX: MEDXF) PLANS TO HOST A CONFERENCE CALL AT 8:00 AM EASTERN TIME ON THURSDAY, NOVEMBER 13, 2025 TO DISCUSS MEDEXUS'S RESULTS FOR ITS SECOND FISCAL QUARTER ENDED SEPTEMBER 30, 2025. MEDEXUS EXPECTS TO FILE ITS FINANCIAL STATEMENTS AND MD&A AFTER MARKETS CLOSE ON NOVEMBER 12, 2025.

MEDXF • Nov. 4, 2025

LIMBACH HOLDINGS, INC. REPORTS THIRD QUARTER 2025 RESULTS

WARRENDALE, PA.--(BUSINESS WIRE)--LIMBACH HOLDINGS, INC. (NASDAQ: LMB) (“LIMBACH” OR THE “COMPANY”) TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025. THIRD QUARTER 2025 HIGHLIGHTS COMPARED TO THIRD QUARTER 2024 TOTAL REVENUE INCREASED 37.8% TO $184.6 MILLION FROM $133.9 MILLION OWNER DIRECT RELATIONSHIPS (“ODR”) REVENUE INCREASED 52.0%, OR $48.4 MILLION, TO $141.4 MILLION, OR 76.6% OF TOTAL REVENUE ORGANIC ODR REVENUE GROWTH OF 12.2% NET INCOME OF $8.8 MILLION, OR.

LMB • Nov. 4, 2025

BABCOCK & WILCOX ANNOUNCES FULL REDEMPTION OF NOTES

AKRON, OHIO--(BUSINESS WIRE)---- $BW--B&W ANNOUNCED THAT WE ISSUED A NOTICE OF REDEMPTION FOR ALL $26 MILLION AGGREGATE PRINCIPAL AMOUNT OUTSTANDING OF OUR 8.125% SENIOR NOTES DUE 2026.

BW • Nov. 4, 2025

RCI DEADLINE: ROSEN, THE FIRST FILING FIRM, ENCOURAGES RCI HOSPITALITY HOLDINGS, INC. INVESTORS WITH LOSSES IN EXCESS OF $100K TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION FIRST FILED BY THE FIRM – RICK

NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF RCI HOSPITALITY HOLDINGS, INC. (NASDAQ: RICK) BETWEEN DECEMBER 15, 2021 AND SEPTEMBER 16, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 20, 2025 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION FIRST FILED BY THE FIRM.

RICK • Nov. 4, 2025

EMX SECURITYHOLDERS APPROVE ARRANGEMENT WITH ELEMENTAL ALTUS

VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - NOVEMBER 4, 2025) - EMX ROYALTY CORPORATION (NYSE AMERICAN: EMX) (TSXV: EMX) (FSE: 6E9) (THE "COMPANY" OR "EMX") IS PLEASED TO ANNOUNCE THAT SHAREHOLDERS OF EMX ("SHAREHOLDERS") AND OPTIONHOLDERS OF EMX WHO HAVE BEEN ISSUED STOCK OPTIONS UNDER EMX'S EXISTING STOCK OPTION PLAN ("OPTIONHOLDERS", AND TOGETHER WITH SHAREHOLDERS, THE "SECURITYHOLDERS") HAVE APPROVED THE PLAN OF ARRANGEMENT (THE "ARRANGEMENT") UNDER THE PROVISIONS OF DIVISION 5 OF PART 9 OF THE BUSINESS CORPORATIONS ACT (BRITISH COLUMBIA) ("BCBCA") INVOLVING EMX, ELEMENTAL ALTUS ROYALTIES CORP. (TSXV: ELE) (OTCQX: ELEMF) ("ELEMENTAL ALTUS") AND 1554829 B.C. LTD. ("ACQUIRECO"), PURSUANT TO WHICH ELEMENTAL ALTUS WILL, AMONG OTHER THINGS, INDIRECTLY THROUGH AN AMALGAMATION OF EMX WITH ACQUIRECO, ACQUIRE ALL OF THE ISSUED AND OUTSTANDING COMMON SHARES OF EMX.

EMX • Nov. 4, 2025

TRAVERE THERAPEUTICS TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES

SAN DIEGO--(BUSINESS WIRE)--TRAVERE THERAPEUTICS, INC. (NASDAQ: TVTX) TODAY ANNOUNCED THAT COMPANY MANAGEMENT WILL PARTICIPATE IN THE FOLLOWING UPCOMING INVESTOR CONFERENCES: GUGGENHEIM'S 2ND ANNUAL HEALTHCARE INNOVATION CONFERENCE PRESENTING ON TUESDAY, NOVEMBER 11, 2025, AT 9:00 A.M. ET STIFEL 2025 HEALTHCARE CONFERENCE WEDNESDAY, NOVEMBER 12, 2025 TD COWEN IMMUNOLOGY & INFLAMMATION SUMMIT PRESENTING ON THURSDAY, NOVEMBER 13, 2025, AT 4:00 P.M. ET JEFFERIES GLOBAL HEALTHCARE CONFERENCE PR.

TVTX • Nov. 4, 2025

PHX ENERGY ANNOUNCES THIRD QUARTER RESULTS & 2026 CAPITAL EXPENDITURE BUDGET

CALGARY, ALBERTA, NOV. 04, 2025 (GLOBE NEWSWIRE) -- THIRD QUARTER HIGHLIGHTS FOR THE THREE-MONTH PERIOD ENDED SEPTEMBER 30, 2025, PHX ENERGY GENERATED CONSOLIDATED REVENUE OF $164.3 MILLION, WHICH IS 2 PERCENT HIGHER THAN THE $160.6 MILLION GENERATED IN THE THIRD QUARTER OF 2024. CONSOLIDATED REVENUE IN THE 2025-QUARTER INCLUDED $11.9 MILLION OF MOTOR RENTAL REVENUE AND $0.3 MILLION OF REVENUE GENERATED FROM THE SALE OF MOTOR EQUIPMENT AND PARTS (2024 - $10.2 MILLION AND $2 MILLION, RESPECTIVELY).

PHX • Nov. 4, 2025

FUTURE FUELS ENGAGES MCS MARKET COMMUNICATION SERVICE GMBH FOR MARKETING SERVICES

VANCOUVER, BC / ACCESS NEWSWIRE / NOVEMBER 4, 2025 / FUTURE FUELS INC. (TSXV:FTUR)(FSE:S0J)(OTCQB:FTURF) ("FUTURE FUELS" OR THE "COMPANY") IS PLEASED TO ANNOUNCE THAT IT HAS ENTERED INTO A 60-DAY MARKETING SERVICES AGREEMENT (THE "AGREEMENT") DATED OCTOBER 31, 2025, WITH MCS MARKET COMMUNICATION SERVICE GMBH ("MCS") OF LÜDENSCHEID, GERMANY. UNDER THE TERMS OF THE AGREEMENT, MCS WILL PROVIDE A RANGE OF ONLINE MARKETING AND INVESTOR AWARENESS SERVICES FOR THE COMPANY, INCLUDING CAMPAIGN CREATION, ADVERTORIAL PRODUCTION, AND DIGITAL ADVERTISING INITIATIVES DESIGNED TO ENHANCE VISIBILITY ACROSS EUROPEAN AND NORTH AMERICAN MARKETS.

FTURF • Nov. 4, 2025

IA FINANCIAL GROUP ANNOUNCES THE RENEWAL OF ITS NORMAL COURSE ISSUER BID

QUEBEC CITY--(BUSINESS WIRE)--WITH THE APPROVAL OF THE TORONTO STOCK EXCHANGE (“TSX”) AND THE AUTORITÉ DES MARCHÉS FINANCIERS, THE BOARD OF DIRECTORS OF IA FINANCIAL CORPORATION INC. (TSX: IAG) (“IA FINANCIAL GROUP” OR THE “CORPORATION”) HAS AUTHORIZED THE CORPORATION TO PURCHASE, IN THE NORMAL COURSE OF ITS ACTIVITIES, FROM NOVEMBER 14, 2025 TO NOVEMBER 13, 2026, UP TO 4,607,178 COMMON SHARES, REPRESENTING APPROXIMATELY 5% OF ITS 92,143,563 COMMON SHARES ISSUED AND OUTSTANDING AS AT OCTOBER 31.

IAFNF • Nov. 4, 2025

DREAM INDUSTRIAL REIT REPORTS STRONG Q3 2025 FINANCIAL RESULTS

TORONTO--(BUSINESS WIRE)--DREAM INDUSTRIAL REAL ESTATE INVESTMENT TRUST (DIR.UN-TSX) OR (THE “REIT” OR “TRUST” OR “DREAM INDUSTRIAL REIT” OR “DIR” OR “WE” OR “US”) TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025. MANAGEMENT WILL HOST A CONFERENCE CALL TO DISCUSS THE FINANCIAL RESULTS ON NOVEMBER 5, 2025 AT 11:00 A.M. (ET). “DREAM INDUSTRIAL REPORTED A STRONG THIRD QUARTER, DELIVERING 4.3% FFO PER UNIT GROWTH AND 6.4% CP NOI GROWTH. LEASING MOMENTUM R.

DREUF • Nov. 4, 2025

NEVADA SUNRISE INVESTOR RELATIONS AGREEMENT

VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - NOVEMBER 4, 2025) - NEVADA SUNRISE METALS CORPORATION (TSXV: NEV) (OTC PINK: NVSGF) ("NEVADA SUNRISE" OR THE "COMPANY") ANNOUNCED TODAY THAT IT HAS ENTERED INTO AN EXPANDED ADVERTISING AND INVESTOR AWARENESS CAMPAIGN WITH DIG MEDIA INC. DOING BUSINESS AS INVESTING NEWS NETWORK ("INN"). INN IS A PRIVATE COMPANY AT ARMS-LENGTH TO NEVADA SUNRISE HEADQUARTERED IN VANCOUVER, BRITISH COLUMBIA, CANADA, DEDICATED TO PROVIDING INDEPENDENT NEWS AND EDUCATION TO INVESTORS SINCE 2007 AT WWW.INVESTINGNEWS.COM.

NVSGF • Nov. 4, 2025

IA FINANCIAL CORPORATION INC. ANNOUNCES THE PAYMENT OF A DIVIDEND ON ITS COMMON AND PREFERRED SHARES

QUEBEC CITY--(BUSINESS WIRE)--THE BOARD OF DIRECTORS OF IA FINANCIAL CORPORATION INC. (TSX: IAG) ANNOUNCED TODAY THE PAYMENT OF A QUARTERLY DIVIDEND OF $0.9900 PER OUTSTANDING COMMON SHARE FOR THE QUARTER ENDED SEPTEMBER 30, 2025. THIS DIVIDEND WILL BE PAYABLE ON DECEMBER 15, 2025, TO ALL COMMON SHAREHOLDERS OF RECORD AT THE CLOSE OF BUSINESS ON NOVEMBER 21, 2025. IA FINANCIAL CORPORATION INC. REMINDS COMMON SHAREHOLDERS WHO WISH TO ENROL IN IA FINANCIAL CORPORATION INC.'S DIVIDEND REINVESTMENT.

IAFNF • Nov. 4, 2025

RADIAN ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS

WAYNE, PA.--(BUSINESS WIRE)--RADIAN GROUP INC. (NYSE: RDN) TODAY REPORTED DILUTED NET INCOME FROM CONTINUING OPERATIONS FOR THE QUARTER ENDED SEPTEMBER 30, 2025, OF $153 MILLION, OR $1.11 PER SHARE. THIS COMPARES WITH DILUTED NET INCOME FROM CONTINUING OPERATIONS FOR THE QUARTER ENDED SEPTEMBER 30, 2024, OF $167 MILLION, OR $1.09 PER SHARE. PRETAX INCOME FROM CONTINUING OPERATIONS FOR THE QUARTER ENDED SEPTEMBER 30, 2025, WAS $199 MILLION COMPARED TO $214 MILLION FOR THE QUARTER ENDED SEPTEMBER.

RDN • Nov. 4, 2025

IA FINANCIAL GROUP REPORTS THIRD QUARTER RESULTS

QUEBEC CITY--(BUSINESS WIRE)--FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025, IA FINANCIAL GROUP (TSX: IAG) RECORDED CORE DILUTED EARNINGS PER COMMON SHARE (EPS)†† OF $3.47, WHICH IS 18% HIGHER THAN THE SAME PERIOD IN 2024 AND WELL ABOVE THE MEDIUM-TERM ANNUAL AVERAGE GROWTH TARGET OF 10%+.1 CORE RETURN ON COMMON SHAREHOLDERS' EQUITY (ROE)†† FOR THE TRAILING 12 MONTHS WAS 17.2%, IN LINE WITH THE 2027 TARGET OF 17%+.1 THIRD QUARTER NET INCOME ATTRIBUTED TO COMMON SHAREHOLDERS WAS $364 MILLION, D.

IAG • Nov. 4, 2025

NEXPOINT REAL ESTATE FINANCE, INC. LAUNCHES $200 MILLION CONTINUOUS OFFERING OF 8.00% SERIES C CUMULATIVE REDEEMABLE PREFERRED STOCK

DALLAS , NOV. 4, 2025 /PRNEWSWIRE/ -- NEXPOINT REAL ESTATE FINANCE, INC. (NYSE: NREF) ("NREF" OR THE "COMPANY") ANNOUNCED TODAY THE LAUNCH OF A CONTINUOUS PUBLIC OFFERING OF UP TO 8,000,000 SHARES OF ITS NEWLY DESIGNATED 8.00% SERIES C CUMULATIVE REDEEMABLE PREFERRED STOCK (THE "SERIES C PREFERRED STOCK") AT A PRICE TO THE PUBLIC OF $25.00 PER SHARE, FOR GROSS PROCEEDS OF $200 MILLION.1 NREF IS A COMMERCIAL MORTGAGE REAL ESTATE INVESTMENT TRUST (REIT) THAT IS PRIMARILY FOCUSED ON INVESTMENTS IN REAL ESTATE SECTORS WHERE ITS SENIOR MANAGEMENT TEAM HAS OPERATING EXPERTISE, INCLUDING IN THE MULTIFAMILY, SINGLE-FAMILY RENTAL, SELF-STORAGE, AND LIFE SCIENCES SECTORS, PREDOMINANTLY IN THE TOP 50 METROPOLITAN STATISTICAL AREAS. THE COMPANY INTENDS TO USE THE NET PROCEEDS FOR GENERAL CORPORATE PURPOSES, WHICH MAY INCLUDE FUNDING INVESTMENTS AND REPAYING AMOUNTS OUTSTANDING UNDER OUR DEBT OBLIGATIONS.

NREF • Nov. 4, 2025

JSPR DEADLINE: JSPR INVESTORS WITH LOSSES IN EXCESS OF $100K HAVE OPPORTUNITY TO LEAD JASPER THERAPEUTICS, INC. SECURITIES FRAUD LAWSUIT

NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF JASPER THERAPEUTICS, INC. (NASDAQ: JSPR) BETWEEN NOVEMBER 30, 2023 AND JULY 3, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 18, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED JASPER THERAPEUTICS SECURITIES DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.

JSPR • Nov. 4, 2025

NUVALENT TO PRESENT PATIENT-REPORTED OUTCOMES DATA FROM ARROS-1 TRIAL OF ROS1-SELECTIVE INHIBITOR, ZIDESAMTINIB, AT 2025 IASLC ASCO NORTH AMERICA CONFERENCE ON LUNG CANCER

ENCORE PIVOTAL EFFICACY AND SAFETY DATA FROM THE ARROS-1 TRIAL ALSO TO BE PRESENTED DURING POSTER SESSION CAMBRIDGE, MASS. , NOV. 4, 2025 /PRNEWSWIRE/ -- NUVALENT, INC. (NASDAQ: NUVL), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON CREATING PRECISELY TARGETED THERAPIES FOR CLINICALLY PROVEN KINASE TARGETS IN CANCER, TODAY ANNOUNCED THE FIRST PRESENTATION OF PATIENT-REPORTED OUTCOMES DATA FROM THE PHASE 2 PORTION OF THE ARROS-1 PHASE 1/2 CLINICAL TRIAL OF ZIDESAMTINIB, AN INVESTIGATIONAL ROS1 INHIBITOR, AS WELL AS ENCORE PIVOTAL EFFICACY AND SAFETY DATA FROM THE ARROS-1 TRIAL, DURING TWO POSTER PRESENTATIONS AT THE 2025 IASLC ASCO NORTH AMERICA CONFERENCE ON LUNG CANCER BEING HELD DECEMBER 5-7, 2025 IN CHICAGO.

NUVL • Nov. 4, 2025